A phase III study of TAK-536 (long-term use study)

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220837

Enrollment

360

Registered

2009-09-01

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential hypertension

Interventions

investigational material(s) Generic name etc : TAK-536 INN of investigational material : Therapeutic category code : 214 Antihypertensives Dosage and Administration for Investigational material : Onc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Main inclusion criteria include the following: 1.Grade I or II essential hypertension, etc.

Exclusion criteria

Exclusion criteria: Main exclusion criteria include the following: 1.Secondary hypertension, grade III hypertension, or malignant hypertension 2.Cardiac disease, cerebrovascular disorder, vascular disease, or hypertensive retinopathy 3.Hyperkalemia 4.Poorly controlled diabetes mellitus, etc

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026